Examkin

Question

Difficulty: MediumEnd-of-Life and Palliative Care

An inpatient palliative care team is consulted for a septuagenarian with metastatic prostate cancer and diffuse bony metastases who was recently admitted to the hospice unit. Over the last 12 hours, the patient has developed acute, severe psychomotor agitation and frightening visual hallucinations. He is attempting to pull out his intravenous line and appears highly distressed. His family is extremely anxious at the bedside.

Arrange the following steps for managing this patient's hyperactive terminal delirium in the most appropriate clinical sequence, from the initial approach to the intervention of last resort for refractory symptoms.

  1. 1Perform a focused assessment to identify and treat easily reversible etiologies, such as urinary retention or uncontrolled pain.
  2. 2Review the patient's current medication list and discontinue any non-essential pharmacological agents with anticholinergic or psychoactive properties.
  3. 3Administer a neuroleptic medication, such as haloperidol, to target severe agitation and perceptual disturbances.
  4. 4Conduct a goals-of-care discussion with the surrogate decision-maker regarding the prognosis and options for proportionate palliative sedation.
  5. 5Initiate continuous palliative sedation with a medication such as midazolam to address intractable suffering.

Answer

The correct sequence is to first assess for reversible causes, then discontinue offending medications, followed by administering an antipsychotic. If symptoms persist, a family discussion regarding prognosis and refractory symptoms should occur, culminating in palliative sedation as a last resort.
The management of terminal hyperactive delirium follows a strict stepwise escalation to ensure ethical and effective symptom control. The initial step is always to identify and treat easily reversible physical triggers (such as a full bladder or uncontrolled pain). Once addressed, the clinician must minimize iatrogenic harm by discontinuing non-essential medications that could be exacerbating the delirium. If the patient remains agitated and distressed, targeted pharmacological management with a neuroleptic (e.g., haloperidol) is instituted. In cases where the delirium is refractory to these standard measures, the clinician must engage the family or surrogate decision-maker in a goals-of-care discussion regarding the intractable nature of the suffering. Only after establishing informed consent should palliative sedation be initiated as a last resort to relieve suffering.

Step-by-Step Solution

1
Evaluate for reversible physical causes.
Identifies immediate triggers like urinary retention, fecal impaction, or pain.
Simple physical interventions can often resolve delirium without adding potentially sedating or adverse-effect-laden medications.
2
Review and simplify the medication list.
Removes anticholinergics or non-essential psychoactive drugs.
Polypharmacy and specific drug classes frequently precipitate or worsen altered mental status and should be minimized.
3
Administer targeted pharmacological therapy (e.g., haloperidol).
Provides symptomatic relief for hyperactive delirium.
When reversible causes are addressed, antipsychotics are the standard first-line treatment for distressing hallucinations and severe agitation.
4
Conduct a family meeting to discuss refractory symptoms.
Aligns the family's understanding with the clinical reality and introduces the concept of palliative sedation.
Shared decision-making and informed consent are ethically required before initiating treatments intended to decrease the patient's level of consciousness.
5
Initiate continuous palliative sedation (e.g., midazolam).
Induces a state of decreased awareness to relieve intractable suffering.
This is the treatment of last resort for symptoms that are entirely refractory to standard therapies and cause severe distress at the end of life.

Key Concept

Stepwise escalation in the management of terminal hyperactive delirium.
Estimated Time:1m 0s
Rate this question

Topics

End-of-Life and Palliative Care

More questions from this topic